{"id":"procyclidine","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Achalasia of esophagus","Angle-closure glaucoma","Atony of colon","Autonomic dysreflexia","Benign prostatic hyperplasia","Bladder outflow obstruction","Bleeding","Brain damage","Chronic heart failure","Chronic lung disease","Complete trisomy 21 syndrome","Disease of liver","Disorder of coronary artery","Disturbance of salivary secretion","Drowsy","Drug AND/OR toxin-induced diarrhea","Gastric ulcer","Gastrointestinal obstruction","Hiatal hernia","Hypertensive disorder","Hyperthyroidism","Kidney disease","Myasthenia gravis","Myocardial dysfunction","Paralytic ileus","Peptic reflux disease","Pyloric obstruction","Retention of urine","Severe chronic ulcerative colitis","Spastic paralysis","Tachyarrhythmia","Toxic megacolon","Ulcerative colitis","Urinary tract obstruction"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL86715","moleculeType":"Small molecule","molecularWeight":"287.45"},"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T16:32:15.400787","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=PROCYCLIDINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:35:44.008146+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:35:50.581982+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PROCYCLIDINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:35:51.321719+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL86715/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:35:51.790984+00:00"}},"allNames":"kemadrine","offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3","modality":"Small Molecule"},"_scrapedAt":"2026-03-28T00:36:30.738Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:35:53.654019+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"indications":{"approved":[{"name":"Arteriosclerotic Parkinsonism","diseaseId":"arteriosclerotic-parkinsonism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Extrapyramidal disease","diseaseId":"extrapyramidal-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Parkinson's disease","diseaseId":"parkinson's-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Parkinsonism","diseaseId":"parkinsonism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Postencephalitic parkinsonism","diseaseId":"postencephalitic-parkinsonism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"_fixedFields":["patents(0)","modality→Small Molecule"],"labelChanges":[],"patentStatus":"Off-patent — no active Orange Book patents","relatedDrugs":[],"trialDetails":[],"_emaApprovals":[],"_faersSignals":[{"count":405,"reaction":"VOMITING"},{"count":330,"reaction":"SCHIZOPHRENIA"},{"count":295,"reaction":"PSYCHOTIC DISORDER"},{"count":283,"reaction":"PNEUMONIA"},{"count":274,"reaction":"DRUG INTERACTION"},{"count":252,"reaction":"NAUSEA"},{"count":225,"reaction":"OFF LABEL USE"},{"count":224,"reaction":"CONDITION AGGRAVATED"},{"count":218,"reaction":"CHOLELITHIASIS"},{"count":212,"reaction":"TOXICITY TO VARIOUS AGENTS"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"_patentsChecked":true,"crossReferences":{"chemblId":"CHEMBL86715"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":174,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"approved","brandName":"Kemadrine","genericName":"PROCYCLIDINE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1955","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:35:53.654019+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}